stack

David Stack appointed to Amarin Board of directors

pharmafile | December 14, 2012 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing Amarin, David Stack 

Biopharma firm Amarin has confirmed that David Stack, president and chief executive of Pacira Pharmaceuticals, has joined its Board of directors as an independent director.

Stack has more than 25 years of successful pharmaceutical industry experience. Beyond his current role as president, he is also a managing director at MPM Capital, and founding partner of Stack Pharmaceuticals.

“The addition of Dave Stack further expands on the operational experience of the Amarin Board of directors and enhances the Board’s outstanding talent and pharmaceutical industry expertise,” said Joseph Zakrzewski, Amarin’s chairman and chief executive.

Advertisement

Stack added: “I look forward to working with Amarin’s Board and management team as the company capitalises on such a significant market opportunity.”

Related Content

medications-money-cure-tablets

Amarin gains positive opinion from Spanish Drug Pricing Committee for national reimbursement of Vazkepa in Spain

Amarin has announced that the Spanish Drug Pricing Committee has recommended the national reimbursement of …

EMA grants marketing authorisation for Amarin’s heart attack treatment

Amarin have been granted authorisation from the EMA to market a treatment that will reduce …

fda2outsideweb

Label expansion of Amarin’s Vascepa has unanimous backing of FDA advisory panel

The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted in favour of expanding …

The Gateway to Local Adoption Series

Latest content